SCHEMBL694188

SCHEMBL694188

NC(=O)c1ccc(-c2cc3c[c]ccc3[nH]2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.50
F2 P00734 2/20 0.43
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
HDAC6 Q9UBN7 1/20 0.40
PRMT5 O14744 1/20 0.40
PRMT3 O60678 1/20 0.40
CARM1 Q86X55 1/20 0.40
EHMT2 Q96KQ7 1/20 0.40
PRMT6 Q96LA8 1/20 0.40
PRMT1 Q99873 1/20 0.40
WDR77 Q9BQA1 1/20 0.40
PRMT8 Q9NR22 1/20 0.40
PRMT7 Q9NVM4 1/20 0.40
MPL P40238 1/20 0.39
ASIC3 Q9UHC3 1/20 0.39
CHEK2 O96017 4/20 0.39
CA12 O43570 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL695278 0.85 F2 (0.43) RIPK1F2CASP3SENP8SENP7
SCHEMBL4793005 0.80 RIPK1 (0.61) RIPK1F2CASP3SENP8SENP7
SCHEMBL695231 0.80 CYP1A1 (0.42) RIPK1CASP3SENP8SENP7SENP6
SCHEMBL6441482 0.78 CASP3 (0.62) RIPK1CASP3SENP8SENP7SENP6
SCHEMBL693160 0.78 F2 (0.58) RIPK1F2CASP3SENP8SENP7
SCHEMBL695386 0.76 CYP1A1 (0.45) CASP3SENP8SENP7SENP6
SCHEMBL694898 0.76 NPC1 (0.63) F2CASP3SENP8SENP7SENP6
SCHEMBL1202420 0.74 FLT3 (0.42)
SCHEMBL695754 0.74 CYP19A1 (0.56) CASP3SENP8SENP7SENP6
SCHEMBL693863 0.73 CLK1 (0.42) CASP3SENP8SENP7SENP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421825-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 EP claimed
WO-2010124108-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 WO claimed
EP-3197450-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2017-08-02 EP disclosed
WO-2016046130-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2016-03-31 WO disclosed
EP-2421825-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 EP disclosed
WO-2010124108-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 WO disclosed